Effects of Bariatric Surgery on Non-metabolic Disease
This chapter provides an overview of the effect of bariatric surgery on a range of obesity-related comorbidities that may not be considered strictly metabolic or inflammatory. This is an arbitrary distinction because there will very likely be metabolic–inflammatory components to all obesity-related comorbidity and physical–weight–pressure-generated effects even in those considered to be metabolic–inflammatory. The chapter focuses on comorbidity beyond type 2 diabetes, lipid disorders, and their effect on cardiovascular risk. Obesity comorbidity should have the following consistent features: the condition should increase in prevalence with increasing obesity, there should be plausible mechanisms that link obesity with the comorbid condition, and there should be an improvement or attenuation of the disease progression in association with weight loss. It is important to consider these criteria carefully as we need to be able to provide our obese patients with realistic expectations about conditions that are likely to improve and possibly even go into remission, and those that may not, following bariatric surgery.
KeywordsObstructive Sleep Apnea Bariatric Surgery Gastric Bypass Stress Urinary Incontinence Sleeve Gastrectomy
- 13.Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005–23.PubMedCrossRefGoogle Scholar